+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Exosomes Market by Product, Workflow, Application, End Use, and by Region - Global Forecast to 2022-2033

  • PDF Icon

    Report

  • 200 Pages
  • January 2023
  • Region: Global
  • Quintana Research and Consulting
  • ID: 5717218
The exosomes market size is estimated to be USD 125.12 million in 2022 and is expected to witness a CAGR of 32.87% during the forecast period 2023-2033. Technological developments in exosome isolation and analytical methods and expansion of exosome clinical applications are some of the factors contributing to the market growth. Additionally, Furthermore, rising incidence of cancer and increase in demand for molecular diagnosis are other factors supporting the market growth. However, strict regulation regarding approval and lack of skilled workforce is expected to hinder the growth.

Rising incidence of cancer is expected to fuel the market growth during the projected period. There is a strong demand for efficient new therapeutic options for the detection and treatment of cancer due to the disease's rising prevalence. For instance, the World Health Organization (WHO) estimated that approximately 10 million people died from cancer in 2020, making it one of the leading causes of death worldwide. Furthermore, as per the American Cancer Society by the end of 2022, there were 609,360 cancer deaths and 1,918,030 new cancer cases in the United States.

Technological developments in exosome isolation and analytical methods are predicted to propel the market growth during the forecast period. For instance, Cell Guidance Systems launched its Instant Exosomes and LipoQ assay kits in November 2022. For research purposes, LipoQ is a lipid quantification assay, and the Instant Exosomes are freeze-dried exosomes. Such improvements are anticipated to increase the use of exosomes for research and market expansion

Segmentation

By Product

The market is categorized into services, kits & reagents, and instruments. In the global market, the kits & reagents segment accounted for the largest revenue share in 2022 owing to the technological advancements. To increase the applications of exosomes, important players are launching cutting-edge kits and reagents. For instance, Clara Biotech introduced their ExoRelease starter kit for the extraction and purification of exosomes in May 2022. Such technologically innovative products support the exploration and improvement of exosome-based therapies and diagnostic applications by assisting researchers in the study of novel biomarkers. These developments are therefore anticipated to fuel segment expansion in the years to come. The services segment is expected to increase rapidly during the forecasted years due to the fact that several market participants are providing exosome services. For instance, the U.S.-based company AMSBIO provides services including exosome extraction & quantification, exosome miRNA isolation & sequencing, exosome surface marker analysis, and proteomics service. As a result, a wide choice of products from numerous companies is anticipated to fuel the industry.

By Workflow

The market is categorized into downstream analysis and isolation methods. In 2022, the downstream analysis segment accounted for the highest revenue share due to growing effectiveness and utility of improved downstream analysis approaches. The usage of analytical techniques including RNA sequencing and mass spectrometry for proteome analysis, and complex sample preparation, downstream data interpretation can be necessary for these processes. Major companies provide a range of technologically cutting-edge products for downstream analysis. For instance, Exosomes can be quantified in 4 hours using the System Biosciences Exo-ELISA Ultra method. The segment is growing as a result of companies providing smart isolation platforms for exosomes that are intact, have a high yield, and can be taken immediately. For example, System Biosciences provides the SmartSEC Platform, which is quick and simple to use and allows for the concurrent analysis of several samples.

By Application

The market is segregated into neurodegenerative diseases, cancer, infectious diseases, cardiovascular diseases, and others. In the global market, the cancer segment accounted for the largest revenue share in 2022 owing to wide range of uses for exosomes in the detection, prognosis, and therapy of cancer. wide range of uses for exosomes in the detection, prognosis, and therapy of cancer. Exosomes have the potential to be exploited for the highly effective therapeutic delivery of RNAs, small chemicals, and proteins to cancer cells. Additionally, studies are being conducted on the lipids, proteins, and nucleic acids transported by exosomes as potential targets for the treatment of cancer and potential biomarkers for the detection and prognosis of cancer. The segment is anticipated to grow in the near future due to the surge in incidence of cancer and the growing importance of early disease detection. The infectious diseases segment is anticipated to grow at a fast CAGR during the forecast period. Numerous infectious diseases are known to have exosomes implicated in their pathogenesis. One of these vesicles' main properties is its capacity to transport a wide range of molecules over short distances or to distant locations, allowing it to regulate a number of biological functions. The development of treatment strategies such as vaccination can use this delivery method. All of these factors are expected to help this segment's revenue generation.

By End Use

The market is segmented into academic & research institutes, pharmaceutical & biotechnology companies, and hospitals & diagnostics centers. In 2022, the pharmaceutical & biotechnology companies segment accounted for the largest revenue share owing to rising demand for medicines and vaccines based on extracellular vesicles. In addition, a number of pharmaceutical and biotechnology companies are collaborating and forming partnerships to enhance large-scale production. For instance, Sartorius AG and RoosterBio collaborated to develop the downstream purification procedures for exosome manufacture in January 2023. Similar to this, in November 2022, Exopharm and Sartorius BIA Separations partnered to enhance the production and commercialization of therapeutic exosomes on a big scale. Such initiatives are expected to drive the segment. The academic & research institutes segment is expected to expand at a substantial CAGR over the projection period. This is due to number of research institutions are placing more emphasis on the usage of exosomes in the discovery and development of new therapies. For instance, researchers at Carnegie Mellon University are attempting to understand the molecular processes involved in exosome-based cell communication in order to apply exosome-based growth factor delivery for regenerative medicine applications. Such research initiatives are anticipated to accelerate segment expansion.

Regional Markets

In 2022, North America region accounted for the highest revenue in the exosomes market and is expected to maintain its dominance during the forecast period. This is attributed to the rise in government investment for the discovery of new biomarkers, existence of important significant players, and prevalence of chronic diseases including cancer and cardiovascular disease. The segment is expected to rise as a result of expanding research and development efforts for the creation of novel medicines, diagnostic techniques, and treatment methods. The Europe region is anticipated to expand rapidly throughout the projected period. The region's expanding governmental and private collaborative initiatives have contributed to ongoing market expansion. For instance, network of experts working in the exosome sector includes the German Society for Extracellular Vesicles. The group works to advance interdisciplinary study and assist rising academic talent in the region's exosomes field. These initiatives will improve the market's long-term growth prospects.

Competitor Insights

Some of the key players operating in the exosomes market are Hologic Inc., Bio-Techne Corporation, Lonza, Miltenyi Biotec, Danaher Corporation, QIAGEN, Abcam plc, Thermo Fisher Scientific, Inc., Fujifilm Holdings Corporation, and RoosterBio, Inc.

To achieve a competitive edge, these companies are implementing a variety of growth strategies. Strategic partnerships, alliances, and agreements with different businesses and research institutions are seen to be the main strategies used by companies in this sector.

For instance, to enable GMP-compliant manufacture of exosome and cell treatments, FUJIFILM Diosynth Biotechnologies and RoosterBio agreed into a strategic partnership in October 2022.

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including product, workflow, application, and end use from 2023 to 2033.

Segmentation: Exosomes Market Report 2022 - 2033

Product (Revenue, USD Million), 2022 - 2033

  • Services
  • Kits & Reagents
  • Instruments

Workflow (Revenue, USD Million), 2022 - 2033

Downstream Analysis

  • Protein Analysis Using Blotting & ELISA
  • Cell Surface Marker Analysis Using Flow Cytometry
  • Proteomic Analysis Using Mass Spectroscopy
  • RNA Analysis With NGS & PCR
  • Others

Isolation Methods

  • Immunocapture On Beads
  • Ultracentrifugation
  • Filtration
  • Precipitation
  • Others

Application (Revenue, USD Million), 2022 - 2033

  • Neurodegenerative Diseases
  • Cancer
  • Infectious Diseases
  • Cardiovascular Diseases
  • Others

End Use (Revenue, USD Million), 2022 - 2033

  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Diagnostics Centers

By Region (Revenue, USD Million), 2022 - 2033

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Framework
1.3.1. Research Models
1.3.1.1. Bottom-up Approach
1.3.1.2. Top-down Approach
1.3.1.3. Data Triangulation
1.3.2. Data Analysis
1.3.2.1. Data Validation
1.3.2.2. Market Size Estimation
1.3.2.3. Market Forecast Model

2. Introduction: Exosomes

3. Executive Summary

4. Market Dynamics
4.1. Market Drivers
4.1.1. Driver 1
4.1.2. Driver 2
4.1.3. Driver 3
4.1.4. Driver 4
4.1.5. Driver 5
4.2. Market Restraint
4.2.1. Restraint 1
4.2.2. Restraint 2
4.2.3. Restraint 3
4.2.4. Restraint 4
4.3. Market Opportunities
4.3.1. Opportunity 1
4.3.2. Opportunity 2
4.3.3. Opportunity 3
4.3.4. Opportunity 4
4.4. Market Trends
4.4.1. Trend 1
4.4.2. Trend 2
4.4.3. Trend 3
4.4.4. Trend 4
4.5. Market Challenges
4.5.1. Challenge 1
4.5.2. Challenge 2
4.5.3. Challenge 3
4.5.4. Challenge 4

5. Market Environment Analysis
5.1. Porter’s 5 Forces Analysis
5.2. PESTEL Analysis
5.3. SWOT Analysis

6. COVID-19 Impact Analysis: Exosomes Market

7. Market Analysis by Product
7.1. Services
7.1.1. Services Market Forecast, 2022-2033 (USD Million)
7.2. Kits & Reagents
7.2.1. Kits & Reagents Market Forecast, 2022-2033 (USD Million)
7.3. Instruments
7.3.1. Instruments Market Forecast, 2022-2033 (USD Million)

8. Market Analysis by Workflow
8.1. Downstream Analysis
8.1.1. Downstream Analysis Market Forecast, 2022-2033 (USD Million)
8.1.1.1. Protein Analysis Using Blotting & ELISA
8.1.1.1.1. Protein Analysis Using Blotting & ELISA Market Forecast, 2022-2033 (USD Million)
8.1.1.2. Cell Surface Marker Analysis Using Flow Cytometry
8.1.1.2.1. Cell Surface Marker Analysis Using Flow Cytometry Market Forecast, 2022-2033 (USD Million)
8.1.1.3. Proteomic Analysis Using Mass Spectroscopy
8.1.1.3.1. Proteomic Analysis Using Mass Spectroscopy Market Forecast, 2022-2033 (USD Million)
8.1.1.4. RNA Analysis With NGS & PCR
8.1.1.4.1. RNA Analysis With NGS & PCR Market Forecast, 2022-2033 (USD Million)
8.1.1.5. Others
8.1.1.5.1. Others Market Forecast, 2022-2033 (USD Million)
8.2. Isolation Methods
8.2.1. Isolation Methods Market Forecast, 2022-2033 (USD Million)
8.2.1.1. Immunocapture On Beads
8.2.1.1.1. Immunocapture On Beads Market Forecast, 2022-2033 (USD Million)
8.2.1.2. Ultracentrifugation
8.2.1.2.1. Ultracentrifugation Market Forecast, 2022-2033 (USD Million)
8.2.1.3. Filtration
8.2.1.3.1. Filtration Market Forecast, 2022-2033 (USD Million)
8.2.1.4. Precipitation
8.2.1.4.1. Precipitation Market Forecast, 2022-2033 (USD Million)
8.2.1.5. Others
8.2.1.5.1. Others Market Forecast, 2022-2033 (USD Million)

9. Market Analysis by Application
9.1. Neurodegenerative Diseases
9.1.1. Neurodegenerative Diseases Market Forecast, 2022-2033 (USD Million)
9.2. Cancer
9.2.1. Cancer Market Forecast, 2022-2033 (USD Million)
9.3. Infectious Diseases
9.3.1. Infectious Diseases Market Forecast, 2022-2033 (USD Million)
9.4. Cardiovascular Diseases
9.4.1. Cardiovascular Diseases Market Forecast, 2022-2033 (USD Million)
9.5. Others
9.5.1. Others Market Forecast, 2022-2033 (USD Million)

10. Market Analysis by End Use
10.1. Academic & Research Institutes
10.1.1. Academic & Research Institutes Market Forecast, 2022-2033 (USD Million)
10.2. Pharmaceutical & Biotechnology Companies
10.2.1. Pharmaceutical & Biotechnology Companies Market Forecast, 2022-2033 (USD Million)
10.3. Hospitals & Diagnostics Centers
10.3.1. Hospitals & Diagnostics Centers Market Forecast, 2022-2033 (USD Million)

10. Regional Market Analysis
10.2. Regional Market Trends

11. North America Exosomes Market
10.1. North America Exosomes Market
10.1.1. North America Market Size and Forecast, 2022-2033 (USD Million)
10.1.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
10.1.1.2. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
10.1.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
10.1.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
10.2. U.S. Exosomes Market
10.2.1. U.S. Market Size and Forecast, 2022-2033 (USD Million)
10.2.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
10.2.1.2. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
10.2.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
10.2.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
10.3. Canada Exosomes Market
10.3.1. Canada Market Size and Forecast, 2022-2033 (USD Million)
10.3.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
10.3.1.2. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
10.3.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
10.3.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)

11. Europe Exosomes Market
11.1. Europe Exosomes Market
11.1.1. Europe Market Size and Forecast, 2022-2033 (USD Million)
11.1.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.1.1.2. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
11.1.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.1.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
11.2. Germany Exosomes Market
11.2.1. Germany Market Size and Forecast, 2022-2033 (USD Million)
11.2.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.2.1.2. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
11.2.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.2.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
11.3. UK Exosomes Market
11.3.1. UK Market Size and Forecast, 2022-2033 (USD Million)
11.3.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.3.1.2. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
11.3.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.3.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
11.4. France Exosomes Market
11.4.1. France Market Size and Forecast, 2022-2033 (USD Million)
11.4.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.4.1.2. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
11.4.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.4.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
11.5. Spain Exosomes Market
11.5.1. Spain Market Size and Forecast, 2022-2033 (USD Million)
11.5.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.5.1.2. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
11.5.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.5.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
11.6. Italy Exosomes Market
11.6.1. Italy Market Size and Forecast, 2022-2033 (USD Million)
11.6.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.6.1.2. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
11.6.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.6.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
11.7. Rest of EuropeExosomes Market
11.7.1. Rest of Europe Market Size and Forecast, 2022-2033 (USD Million)
11.7.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
11.7.1.2. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
11.7.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
11.7.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)

12. Asia PacificExosomes Market
12.1. Asia PacificExosomes Market
12.1.1. Asia Pacific Market Size and Forecast, 2022-2033 (USD Million)
12.1.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.1.1.2. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
12.1.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
12.1.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
12.2. Japan Exosomes Market
12.2.1. Japan Market Size and Forecast, 2022-2033 (USD Million)
12.2.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.2.1.2. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
12.2.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
12.2.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
12.3. China Exosomes Market
12.3.1. China Market Size and Forecast, 2022-2033 (USD Million)
12.3.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.3.1.2. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
12.3.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
12.3.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
12.4. India Exosomes Market
12.4.1. India Market Size and Forecast, 2022-2033 (USD Million)
12.4.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.4.1.2. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
12.4.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
12.4.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
12.5. South Korea Exosomes Market
12.5.1. South Korea Market Size and Forecast, 2022-2033 (USD Million)
12.5.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.5.1.2. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
12.5.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
12.5.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
12.6. Australia Exosomes Market
12.6.1. Australia Market Size and Forecast, 2022-2033 (USD Million)
12.6.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.6.1.2. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
12.6.1.3. Market Size and Forecast by Application 2022-2033 (USD Million)
12.6.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
12.7. Rest of Asia Pacific Exosomes Market
12.7.1. Rest of Asia Pacific Market Size and Forecast, 2022-2033 (USD Million)
12.7.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
12.7.1.2. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
12.7.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
12.7.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)

13. Latin America Exosomes Market
13.1. Latin America Exosomes Market
13.1.1. Latin America Market Size and Forecast, 2022-2033 (USD Million)
13.1.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
13.1.1.2. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
13.1.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
13.1.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
13.2. BrazilExosomes Market
13.2.1. Brazil Market Size and Forecast, 2022-2033 (USD Million)
13.2.1.1. Market Size and Forecast by Application, 2022-2033 (USD Million)
13.2.1.2. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
13.2.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
13.2.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
13.3. MexicoExosomes Market
13.3.1. Mexico Market Size and Forecast, 2022-2033 (USD Million)
13.3.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
13.3.1.2. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
13.3.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
13.3.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
13.4. Argentina Exosomes Market
13.4.1. Argentina Market Size and Forecast, 2022-2033 (USD Million)
13.4.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
13.4.1.2. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
13.4.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
13.4.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
13.5. Rest of Latin America Exosomes Market
13.5.1. Rest of Latin America Market Size and Forecast, 2022-2033 (USD Million)
13.5.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
13.5.1.2. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
13.5.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
13.5.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)

14. MEAExosomes Market
14.1. MEA Exosomes Market
14.1.1. MEA Market Size and Forecast, 2022-2033 (USD Million)
14.1.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
14.1.1.2. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
14.1.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
14.1.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
14.2. GCC Exosomes Market
14.2.1. GCC Market Size and Forecast, 2022-2033 (USD Million)
14.2.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
14.2.1.2. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
14.2.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
14.2.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
14.3. South Africa Exosomes Market
14.3.1. South Africa Market Size and Forecast, 2022-2033 (USD Million)
14.3.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
14.3.1.2. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
14.3.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
14.3.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
14.4. Rest of MEA Exosomes Market
14.4.1. Rest of MEA Market Size and Forecast, 2022-2033 (USD Million)
14.4.1.1. Market Size and Forecast by Product, 2022-2033 (USD Million)
14.4.1.2. Market Size and Forecast by Workflow, 2022-2033 (USD Million)
14.4.1.3. Market Size and Forecast by Application, 2022-2033 (USD Million)
14.4.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)

15. Competitor Analysis
15.1. Market Share Analysis, 2022
15.2. Major Recent Developments, 2019-2022

16. Company Profiles
16.1. Hologic Inc.
16.1.1. Company Snapshot
16.1.2. Company Overview
16.1.3. Financial Analysis
16.1.4. Product Benchmarking
16.1.5. Recent Developments
16.2. Bio-Techne Corporation
16.2.1. Company Snapshot
16.2.2. Company Overview
16.2.3. Financial Analysis
16.2.4. Product Benchmarking
16.2.5. Recent Developments
16.3. Lonza
16.3.1. Company Snapshot
16.3.2. Company Overview
16.3.3. Financial Analysis
16.3.4. Product Benchmarking
16.3.5. Recent Developments
16.4. Miltenyi Biotec
16.4.1. Company Snapshot
16.4.2. Company Overview
16.4.3. Financial Analysis
16.4.4. Product Benchmarking
16.4.5. Recent Developments
16.5. Danaher Corporation
16.5.1. Company Snapshot
16.5.2. Company Overview
16.5.3. Financial Analysis
16.5.4. Product Benchmarking
16.5.5. Recent Developments
16.6. QIAGEN, Abcam plc
16.6.1. Company Snapshot
16.6.2. Company Overview
16.6.3. Financial Analysis
16.6.4. Product Benchmarking
16.6.5. Recent Developments
16.7. Thermo Fisher Scientific, Inc.
16.7.1. Company Snapshot
16.7.2. Company Overview
16.7.3. Financial Analysis
16.7.4. Product Benchmarking
16.7.5. Recent Developments
16.8. Fujifilm Holdings Corporation
16.8.1. Company Snapshot
16.8.2. Company Overview
16.8.3. Financial Analysis
16.8.4. Product Benchmarking
16.8.5. Recent Developments
16.9. RoosterBio, Inc.
16.9.1. Company Snapshot
16.9.2. Company Overview
16.9.3. Financial Analysis
16.9.4. Product Benchmarking
16.9.5. Recent Developments
16.10. Company 10
16.10.1. Company Snapshot
16.10.2. Company Overview
16.10.3. Financial Analysis
16.10.4. Product Benchmarking
16.10.5. Recent Developments
16.11. Company 11
16.11.1. Company Snapshot
16.11.2. Company Overview
16.11.3. Financials
16.11.4. Workflow Benchmarking
16.11.5. Recent Developments
16.12. Company 12
16.12.1. Company Snapshot
16.12.2. Company Overview
16.12.3. Financials
16.12.4. Workflow Benchmarking
16.12.5. Recent Developments
16.13. Company 13
16.13.1. Company Snapshot
16.13.2. Company Overview
16.13.3. Financials
16.13.4. Workflow Benchmarking
16.13.5. Recent Developments
16.14. Company 14
16.14.1. Company Snapshot
16.14.2. Company Overview
16.14.3. Financials
16.14.4. Workflow Benchmarking
16.14.5. Recent Developments
16.15. Company 15
16.15.1. Company Snapshot
16.15.2. Company Overview
16.15.3. Financials
16.15.4. Workflow Benchmarking
16.15.5. Recent Developments
16.16. Others Prominent Players

17. Conclusion & Recommendations

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Hologic Inc.
  • Bio-Techne Corporation
  • Lonza
  • Miltenyi Biotec
  • Danaher Corporation
  • QIAGEN
  • Abcam plc
  • Thermo Fisher Scientific Inc.
  • Fujifilm Holdings Corporation
  • RoosterBio Inc.